Cargando…
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
Endometrial and cervical cancers, uterine myoma, and endometriosis are very common uterine diseases. Worldwide, more than 800,000 women are affected annually by gynecological cancers, as a result of which, more than 360,000 die. During their reproductive age, about 70% of women develop uterine myoma...
Autor principal: | Rižner, Tea Lanišnik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301985/ https://www.ncbi.nlm.nih.gov/pubmed/22419909 http://dx.doi.org/10.3389/fphar.2012.00034 |
Ejemplares similares
-
Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021) -
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2020) -
AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
por: Hojnik, Marko, et al.
Publicado: (2022) -
Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
por: Sinreih, Maša, et al.
Publicado: (2021)